Absci Corp (ABSI) USD0.0001

Sell:$2.76Buy:$2.77$0.08 (2.97%)

NASDAQ:1.02%
Market closed | Prices delayed by at least 15 minutes
Sell:$2.76
Buy:$2.77
Change:$0.08 (2.97%)
Market closed | Prices delayed by at least 15 minutes
Sell:$2.76
Buy:$2.77
Change:$0.08 (2.97%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Absci Corporation is a clinical-stage biopharmaceutical company advancing therapeutics with generative design. Its Integrated Drug Creation platform combines artificial intelligence (AI) models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. Its approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Alongside collaborations with pharmaceutical, biotech, tech, and academic companies, the Company is advancing its own pipeline of AI- designed therapeutics. These include ABS-101, an antibody to treat inflammatory bowel disease (IBD), as well as other indications, and ABS-201, for hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern baldness. It has four wholly owned, internally developed programs focusing on cytokine biology. Its other pipeline programs include ABS-301 and ABS-501.

Key people

Sean Mcclain
Chief Executive Officer, Founder, Director
Zachariah Jonasson
Chief Financial Officer, Chief Business Officer
Andreas Busch
Chief Innovation Officer
Shelby J. Walker
Chief Legal Officer
Frans Van Houten
Independent Chairman of the Board
Karen K. Mcginnis
Independent Director
Menelas Pangalos
Independent Director
Daniel A. Rabinovitsj
Independent Director
Joseph Sirosh
Independent Director
Click to see more

Key facts

  • EPIC
    ABSI
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US00091E1091
  • Market cap
    $343.13m
  • Employees
    156
  • Shares in issue
    127.56m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.